Orange County NC Website
Browse       Search
Revised -XO\ <br />Implementation (Continued): <br />•The Exposure Control Program consists of specific program components that are <br />identified as follows: <br />o Exposure Control Policy Statement <br />o Exposure Control Plan <br />o Exposure Control Roles and Responsibilities <br />o Standard Operating Procedures: <br />EC 1: Health Maintenance <br />EC 2: Exposure Control Training <br />EC 3: Station/Work Area Environment <br />EC 4: Personal Protective Equipment <br />EC 5: Scene Operations <br />EC 6: Post-Response <br />EC 7: Post-Exposure Protocols <br />EC 8: Compliance and Quality Monitoring <br />EC 9: Annual Review of Exposure Plan <br />EC 10: Engineered Sharps / Needle less System <br />EC 11: Hepatitis B Vaccine / Post Exposure Evaluation <br />o Appendix: <br />1: Definitions <br />2: Approved disinfectants <br />3: Laundry Procedure <br />4: Report of Occupational Exposure <br />5: Respirator Use Form <br />6: Treatment Declination Form <br />7: Hepatitis B Vaccine Declination Form <br />8: OSHA 29 CFR 1910.1030 <br />Evaluation of Exposure Incidents: <br />•The procedure for the evaluation / investigation of circumstances surrounding <br />incidents of potential exposure to blood, body fluids, or other potentially infectious <br />materials is detailed in SOP EC 7: Post Exposure Protocols. This SOP also <br />identifies medical follow-up, documentation, recordkeeping and confidentiality <br />requirements. <br />Compliance Methods: <br />•Universal precautions will be observed at this facility in order to prevent contact <br />with blood or other potentially infectious materials. All blood or other potentially <br />infectious material will be considered infectious regardless of the perceived <br />status of the source individual. <br />•Engineering and work practice controls will be utilized to eliminate or minimize <br />exposure to employees at this facility. Engineering controls are the primary <br />means of eliminating or minimizing employee exposure and include the use of <br />safer medical devices, such as needle-less devices, shielded needle devices, <br />and plastic capillary tubes. Medical devices with engineered sharps injury <br />protections and needle-less systems constitute an effective engineering control <br />and must be used where feasible. <br />DocuSign Envelope ID: 79C5D167-B6CA-4E59-B4AC-AA38CC1B20BD